Роль антагонистов кальция в лечении сердечно-сосудистых заболеваний: фокус на дилтиазем
- Авторы: Барышникова Г.А.1, Чорбинская С.А.1, Степанова И.И.1
-
Учреждения:
- ФГБУ Учебно-научный медицинский центр Управления делами Президента РФ, Москва
- Выпуск: Том 6, № 1 (2015)
- Страницы: 76-82
- Раздел: Статьи
- URL: https://journals.rcsi.science/2221-7185/article/view/45175
- DOI: https://doi.org/10.26442/CS45175
- ID: 45175
Цитировать
Полный текст
Аннотация
Полный текст
Открыть статью на сайте журналаОб авторах
Галина Анатольевна Барышникова
ФГБУ Учебно-научный медицинский центр Управления делами Президента РФ, Москва
Email: bargalan@mail.ru
д-р мед. наук, проф. каф. семейной медицины ФГБУ УНМЦ Управления делами ПрезидентаРФ 121359, Россия, Москва, ул. Маршала Тимошенко, д. 21
Светлана Алексеевна Чорбинская
ФГБУ Учебно-научный медицинский центр Управления делами Президента РФ, Москвад-р мед. наук, проф., зав. каф. семейной медицины ФГБУ УНМЦ Управления делами Президента РФ 121359, Россия, Москва, ул. Маршала Тимошенко, д. 21
Ирина Ираклиевна Степанова
ФГБУ Учебно-научный медицинский центр Управления делами Президента РФ, Москваканд. мед. наук, доц. каф. семейной медицины ФГБУ УНМЦ Управления делами Президента РФ 121359, Россия, Москва, ул. Маршала Тимошенко, д. 21
Список литературы
- Fleckenstein A, Tritthart H, Fleckenstein B et al. Eineneue Gruppe - kompetitiver Ca++ Antagonisten (Iproveratril, D6000, Prenylamin) mitstarken Hemeffekten auf die elektromekanische Koppelungim Warmbluter - myocard. Pflugers Arch 1969; 307: R25.
- Grossman E, Messerli F.H. Calcium antagonists. Progress Cardiovascular Dis 2004; 47 (1): 34-57.
- Hoberg E, Schwarz F, Schoemig A et al. Prevention of restenosis by verapamil. The verapamil Angioplasty Study (VAS). Circulation 1990; 82 (Suppl. 3): 428.
- Schroeder J.S, Gao S.Z, Alderman E.L et al. A preliminary study of diltiazem in the prevention of coronary artery disease in heart - transplant recipients. N Eng J Med 1993; 328 (3): 164-70.
- Zanchetti A, Rosei E.A, Dal Palu C et al. The Verapamil in Hypertension and Atherosclerosis Study (VHAS): Results of long - term randomized treatment with either verapamil or chlorthalidone on carotid intima - media thickness. J Hypertens 1998; 16: 1667-76.
- Furberg C.D, Psaty B.M, Meyer J.V. Dose - related increase in mortality in patients with coronary artery disease. Circulation 1995; 92: 1326-31.
- Psaty B.M, Heckbert S.R, Koepsell T.D et al. The risk of myocardial infarction assocoated with antihypertensive drug therapies. JAMA 1995; 274: 620-5.
- Рекомендации Минздрава России. Диагностика и лечение хронической ишемической болезни сердца. 2013.
- Рекомендации РМОАГ/ВНОК по диагностике и лечению артериальной гипертонии (4-й пересмотр), 2010.
- Kannel W.B, Kannel C, Paffenbarger R.S et al. Heart rate and cardiovascular mortality: the Framingham Study. Am Heart J 1987; 113: 1489-94.
- Gillman M, Kannel W, Belanger A et al. Influence of heart rate on mortality among persons with hypertension: The Framingham study. Am Heart J 1993; 125: 1148-54.
- Pool P.E, Massie B.M, Venkataraman K et al. Diltiazem as monotherapy for systemic hypertension: a multicenter, randomized, placebo - controlled trial. Am J Cardiol 1986; 57 (4): 212-7.
- Zannad F, Gosse P, Bernard-Fernier M.F, de La Garoullaye A. Antihypertensive efficacy and tolerability of diltiazem and enalapril, alone or in combination. DESG. Diltiazem Enalapril Study Group. Presse Med 1994; 23 (29): 1335-8.
- Watts R.W, Wing L.M. A placebo - controlled comparison of diltiazem and amlodipine monotherapy in essential hypertension using 24-h ambulatory monitoring. Blood Press 1998; 7 (1): 25-30.
- Abernethy D.R, Montamat S.C. Acute and chronic studies of diltiazem in elderly vs. young hypertensive patients. Am J Cardiol 1987; 60 (17): 1161-201.
- Materson B.J, Reda D.J, Cushman W.C et al. Single drug therapy for hypertension in men. A comparison of 6 antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. N Engl J Med 1993; 328: 914-21.
- Hansson L, Hedner T, Lund-Johansen P et al. Randomised trial of effects of calcium antagonists compared with diuretics and b - blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study. Lancet 2000; 356 (9227): 359-65.
- Weiss R.J, Bent B. Diltiazem - induced left ventricular mass regression in hypertensive patients. J Clin Hypertens 1987; 3 (2): 135-43.
- De Rosa M.L, Giordano A, Melfi M et al. Antianginal efficacy over 24 hours and exercise hemodynamic effects once - daily sustained - release 300 mg diltiazem and 240 mg verapamil in stable angina pectoris. Int J Cardiol 1998; 63: 27-35.
- Deedwania P.C, Pool P.E, Thadani U, Eff J. Effect of morning vs. evening dosing of diltiazem on myocardial ischemia detected by ambulatory electrocardiographic monitoring in chronic stable angina pectoris. Am J Cardiol 1997; 80: 421-5.
- Stone P.H, Gibson R.S, Glasser S.P et al. ASIS Study group. Comparison of propranolol, diltiazem, and nifedipine in the treatment of ambulatory ischemia in patients with stable angina. Circulation 1990; 82: 1962-72.
- Deanfield J.E. Amlodipine vs. diltiazem CR in the reduction of the total ischemic burden: the Circadian Anti - Ischemia Program in Europe (CAPE) II trial - clinical rationale and methodology. Cardiovasc Drug Ther 1998; (12 Suppl. 3): 239-42.
- Frishman W, Charlap S, Kümmel B et al. Diltiazem, nifedipine and their combination in patients with stable angina pectoris: effect on angina, exercise tolerance, and the ambulatory electrocardiographic ST segment. Circulation 1988; 77: 774-86.
- Nadeau C, Hilton D, Savard D et al. Three - month efficacy and safety of once - daily diltiazem in chronic stable angina pectoris. Am J Cardiol 1995; 75: 555-8.
- Waters D, Juneau M, Baierd M. Role of diltiazem in the treatment of silent myocardial ischemia. J Cardiovasc Pharmacol 1991; 18 (Suppl. 9): s15-20.
- Theroux P, Baird M, Juneau M. Effect of diltiazem upon symptomatic and asymptomatic episodes of ST segment depression occurring during daily life and during exercise. Circulation 1991; 84: 15-22.
- Opie L.H. Calcium antagonists in the management of anginal syndromes. Changing concepts in relation to the role of coronary vasospasm. Progr Cardiovasc Dis 1996; 38: 291-314.
- Gubel E.J, Hautvast A.M, Gilst van W et al. Randomised, double - blind trial of intravenous diltiazem vs. glyceryl trinitrate for stable angina pectoris. Lancet 1995; 346: 1653-7.
- Therous P, Taeymans Y, Morissette D et al. A randomized study comparing propranolol and diltiazem in the treatment of unstable angina. J Am Coll Cardiol 1985; 5: 717-22.
- Gibson R.S, Boden W.E, Therous P et al. Diltiazem and reinfarction in patients with non-Q-wave myocardial infarction. Results of a double - blind, randomized, multicenter trial. N Engl J Med 1986; 315: 423-9.
- Goldstein R.E, Boccuzzi S.J, Cruess D et al. Multicenter Diltiazem Postinfarction Research Group. Diltiazem increases late - onset congestive heart failure in post infarction patients with early reduction in ejection fraction. Circulation 1991; 83: 52-60.
- Boden W.E, Krone R.J, Kleiger R.E. Electrocardiographic subset analysis of diltiazem administration on long - term outcome after acute myocardial infarction. The Multicenter Diltiazem Post - In - farction Trial Research Group. Am J Cardiol 1991; 67 (5): 335-42.
- Moss A.J, Oakes D, Rubison M et al. Effects of diltiazem on long - term outcome after acute myocardial infarction in patients with and without a history of systemic hypertension. The Multicenter Diltiazem Postinfarction Trial Research Group. Am J Cardiol 1991; 68: 429-33.
- Gibson R.S, Hansen J.F, Messerli F et al. Long - term effects of diltiazem and verapamil on mortality and cardiac events in non-Q- wave acute myocardial infarction without pulmonary congestion: post hoc subset analysis of the multicenter diltiazem post infarction trial and the second danish verapamil infarction trial studies. Am J Cardiol 2000; 86: 275-9.
- Gibson R.S, Boden W.E, Theroux P et al. Diltiazem and reinfarction in patients with non-Q-wave myocardial infarction. Results of a double - blind, randomized, multicenter trial. N Engl J Med 1986; 315: 423-9.
- Boden W.E, Gilst van W.H, Scheldewaert R.G et al. Diltiazem in acute myocardial infarction treated with thrombolytic agents: a randomised placebo - controlled trial. Incomplete Infarction Trial of European Research Collaborators Evaluating Prognosis post - Thrombolysis (INTERCEPT). Lancet 2000; 355 (9217): 1751-6.
- Nayler W.G. Calcium antagonists and the ischemic myocardium. Int J Cardiol 1987; 15: 267-85.
- Rosing D.R, Kent K.M, Maron B.J, Epstein S.E. Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. II. Effects on exercise capacity and symptomatic status. Circulation 1979; 60: 1208-13.
- Bonow R.O, Dilsizian V, Rosing D.R et al. Verapamil - induced im - provement in left ventricular diastolic filling and increased exercise tolerance in patients with hypertrophic cardiomyopathy: short - and long - term effects. Circulation 1985; 72: 853-64.
- Figulla H, Gietzen F, Raiber M et al. DiDi Study Group. Diltiazem improves cardiac function and exercise capacity in patients with dilated cardiomyopathy. Results of the diltiazem in dilated cardiomyopathy trial. Circulation 1996; 94: 346-52.
- Opie L. Calcium channel antagonists: part III: Use and comparative efficacy in hypertension and supra ventricular arrhythmias. Minor indications. In: L.H Opie ed. Clinical use of calcium channel antagonist drugs. 2nd ed. Boston, Dordrecht, London: Kluwer Acad. Publishers 1990.
- Roth A, Harrison E, Mitani et al. Efficacy and safety medium - and high - dose diltiazem alone and in combination with digoxin for control of heart rate at rest and during exercise in patients with chronic atrial fibrillation. Circulation 1986; 73: 316-24.
- Cobbe S.M. Using the right drug. A treatment algorithm for atrial fibrillation. Eur Heart J 1997; 18 (Suppl. C): c33-9.
- Диагностика и лечение фибрилляции предсердий. Рекомендации РКО, ВНОА и АССХ, 2012.
- Pozet N, Brasier J, Aissa A et al. Pharmacokinetics of diltiazem in severe renal failure. Eur J Clin Pharmacol 1983; 24: 635-8.
- Pérez-Maraver M, Carrera M.J, Mical T et al. Renoprotective effect of diltiazem in hypertensive type 2 diabetic patients with persistent microalbuminuria despite ACE inhibitor treatment. Diabetes Res Clin Pract 2005; 70 (1): 13-9.
- Hricik D.E, Levine B.S, Adrogue H.J et al. Evaluation of enalapril/diltiazem ER in hypertensive patients with coexisting renal dysfunction. Enalapril/Diltiazem ER in Hypertensive Renal Disease Group. J Hum Hypertens 1996; 10 (11): 769-74.
- Triggle D. Sites, mechanism of action, and differentiation of calcium channels antagonists. Am J Hypertens 1991; 4: s422-9.
- Ginsberg D, Pappas J.E, Rofman B.A et al. Once - daily dosing of sustained - release diltiazem capsules in mild - to - moderate hypertension. J Am Osteopath Assoc 1988; 88 (12): 1489-92.